| [1] |
Higgins RD, Jobe AH, Koso-Thomas M, et al. Bronchopulmonary dysplasia: executive summary of a workshop[J]. J Pediatr, 2018, 197: 300-308. DOI: 10.1016/j.jpeds.2018.01.043.
|
| [2] |
Jensen EA, Edwards EM, Greenberg LT, et al. Severity of bronchopulmonary dysplasia among very preterm infants in the united states[J]. Pediatrics, 2021, 148(1): e2020030007. DOI: 10.1542/peds.2020-030007.
|
| [3] |
|
| [4] |
Pierro M, Van Mechelen K, van Westering-Kroon E, et al. Endotypes of prematurity and phenotypes of bronchopulmonary dysplasia: toward personalized neonatology[J]. J Pers Med, 2022, 12(5): 687. DOI: 10.3390/jpm12050687.
|
| [5] |
Cheong JLY, Doyle LW. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia[J]. Semin Perinatol, 2018, 42(7): 478-484. DOI: 10.1053/j.semperi.2018.09.013.
|
| [6] |
Principi N, Di Pietro GM, Esposito S. Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies[J]. J Transl Med, 2018, 16(1): 36. DOI: 10.1186/s12967-018-1417-7.
|
| [7] |
Hennelly M, Greenberg RG, Aleem S. An update on the prevention and management of bronchopulmonary dysplasia[J]. Pediatric Health Med Ther, 2021, 12: 405-419. DOI: 10.2147/PHMT.S287693.
|
| [8] |
Omar SA, Abdul-Hafez A, Ibrahim S, et al. Stem-cell therapy for bronchopulmonary dysplasia (BPD) in newborns[J]. Cells, 2022, 11(8): 1275. DOI: 10.3390/cells11081275.
|
| [9] |
Jiménez J, Lesage F, Richter J, et al. Upregulation of vascular endothelial growth factor in amniotic fluid stem cells enhances their potential to attenuate lung injury in a preterm rabbit model of bronchopulmonary dysplasia[J]. Neonatology, 2018, 113(3): 275-285. DOI: 10.1159/000481794.
|
| [10] |
Liu QW, Huang QM, Wu HY, et al. Characteristics and therapeutic potential of human amnion-derived stem cells[J]. Int J Mol Sci, 2021, 22(2): 970. DOI: 10.3390/ijms22020970.
|
| [11] |
Zakrzewski W, Dobrzyński M, Szymonowicz M, et al. Stem cells: past, present, and future[J]. Stem Cell Res Ther, 2019, 10(1): 68. DOI: 10.1186/s13287-019-1165-5.
|
| [12] |
Akle CA, Adinolfi M, Welsh KI, et al. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers[J]. Lancet, 1981, 2(8254): 1003-1005. DOI: 10.1016/s0140-6736(81)91212-5.
|
| [13] |
Miki T, Lehmann T, Cai H, et al. Stem cell characteristics of amniotic epithelial cells[J]. Stem Cells, 2005, 23(10): 1549-1559. DOI: 10.1634/stemcells.2004-0357.
|
| [14] |
Miki T. Stem cell characteristics and the therapeutic potential of amniotic epithelial cells[J]. Am J Reprod Immunol, 2018, 80(4): e13003. DOI: 10.1111/aji.13003.
|
| [15] |
|
| [16] |
Schmidt AR, Ramamoorthy C. Bronchopulmonary dysplasia[J]. Paediatr Anaesth, 2022, 32(2): 174-180. DOI: 10.1111/pan.14365.
|
| [17] |
Tan JL, Lau SN, Leaw B, et al. Amnion epithelial cell-derived exosomes restrict lung injury and enhance endogenous lung repair[J]. Stem Cells Transl Med, 2018, 7(2): 180-196. DOI: 10.1002/sctm.17-0185.
|
| [18] |
Zhang S, Jiang W, Ma L，et al. Nrf2 transfection enhances the efficacy of human amniotic mesenchymal stem cells to repair lung injury induced by lipopolysaccharide[J]. J Cell Biochem, 2018, 119(2): 1627-1636. DOI: 10.1002/jcb.26322.
|
| [19] |
Giusto K, Wanczyk H, Jensen T, et al. Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies[J]. Dis Model Mech, 2021, 14(2): dmm047753. DOI: 10.1242/dmm.047753.
|
| [20] |
Papagianis PC, Ahmadi-Noorbakhsh S, Lim R, et al. The effect of human amnion epithelial cells on lung development and inflammation in preterm lambs exposed to antenatal inflammation[J]. PLoS One, 2021, 16(6): e0253456. DOI: 10.1371/journal.pone.0253456.
|
| [21] |
Lim R, Malhotra A, Tan J, et al. First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study[J]. Stem Cells Transl Med, 2018, 7(9): 628-635. DOI: 10.1002/sctm.18-0079.
|
| [22] |
Malhotra A, Lim R, Mockler JC, et al. Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia[J]. Stem Cells Transl Med, 2020, 9(3): 289-294. DOI: 10.1002/sctm.19-0251.
|
| [23] |
Zhu D, Krause M, Yawno T, et al. Assessing the impact of gestational age of donors on the efficacy of amniotic epithelial cell-derived extracellular vesicles in experimental bronchopulmonary dysplasia[J]. Stem Cell Res Ther, 2022, 13(1): 196. DOI: 10.1186/s13287-022-02874-4.
|
| [24] |
He F, Zhou A, Feng S. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: a systematic review and Meta-analysis[J]. PLoS One, 2018, 13(5): e0197658. DOI: 10.1371/journal.pone.0197658.
|
| [25] |
Zhu D, Kusuma GD, Schwab R, et al. Prematurity negatively affects regenerative properties of human amniotic epithelial cells in the context of lung repair[J]. Clin Sci (Lond), 2020, 134(20): 2665-2679. DOI: 10.1042/CS20200859.
|
| [26] |
Royce SG, Patel KP, Mao W, et al. Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease[J]. Br J Pharmacol, 2019, 176(13): 2195-2208. DOI: 10.1111/bph.14666.
|
| [27] |
Cargnoni A, Romele P, Bonassi Signoroni P, et al. Amniotic MSCs reduce pulmonary fibrosis by hampering lung B-cell recruitment, retention, and maturation[J]. Stem Cells Transl Med, 2020, 9(9): 1023-1035. DOI: 10.1002/sctm.20-0068.
|
| [28] |
Brown J, Barry C, Schmitz MT, et al. Interspecies chimeric conditions affect the developmental rate of human pluripotent stem cells[J]. PLoS Comput Biol, 2021, 17(3): e1008778. DOI: 10.1371/journal.pcbi.1008778.
|
| [29] |
Li J, Qiu C, Zhou J, et al. Repair of retinal degeneration by human amniotic epithelial stem cell-derived photoreceptor-like cells[J]. Int J Mol Sci, 2022, 23(15): 8722. DOI: 10.3390/ijms23158722.
|
| [30] |
Jafari A, Rezaei-Tavirani M, Farhadihosseinabadi B, et al. Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin[J]. Stem Cell Res Ther, 2021, 12(1): 126. DOI: 10.1186/s13287-021-02196-x.
|
| [31] |
Yang PJ, Yuan WX, Liu J, et al. Biological characterization of human amniotic epithelial cells in a serum-free system and their safety evaluation[J]. Acta Pharmacol Sin, 2018, 39(8): 1305-1316. DOI: 10.1038/aps.2018.22.
|
| [32] |
Qiu C, Ge Z, Cui W, et al. Human amniotic epithelial stem cells: a promising seed cell for clinical applications[J]. Int J Mol Sci, 2020, 21(20): 7730. DOI: 10.3390/ijms21207730.
|
| [33] |
Tan JL, Tan YZ, Muljadi R, et al. Amnion epithelial cells promote lung repair via lipoxin A4[J]. Stem Cells Transl Med, 2017, 6(4): 1085-1095. DOI: 10.5966/sctm.2016-0077.
|
| [34] |
Baker EK, Malhotra A, Lim R, et al. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase Ⅰ dose escalation study[J]. BMJ Open, 2019, 9(2): e026265. DOI: 10.1136/bmjopen-2018-026265.
|